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Abstract
Background Amblyopia (prevalence 3.4%) is in principle
treatable, but approximately one quarter of children do not
reach reading acuity in the amblyopic eye. Adults with
persistent amblyopia and/or strabismus experience a de-
crease in quality of life. This was now quantified by
patient-perceived utility values.
Methods Subjects were born 1962–1972 and had been
treated by occlusion therapy for amblyopia by one
orthoptist 30–35 years ago. All children in Waterland with
amblyopia and/or strabismus had been referred to this
orthoptist. Utilities were derived by methods of time trade-
off, TTO (lifetime traded against perfect vision) and
standard gamble, SG (death risk accepted for perfect
vision). Most troubling eye disorder (low acuity of the
amblyopic eye, lacking stereopsis or strabismus) was
chosen and ranked among nine chronic disorders according
to the subject’s perceived severity.
Results From 201 patients that could be contacted 35 years
after occlusion therapy — out of 471 who had been
occluded — 135 were included: 17 could not be reached,
34 refused, and 15 had other reasons to not participate.
Mean age was 40.86 years; 53% were male. Seventy
percent were willing to trade lifetime according to the TTO
method; its mean (log) utility was 0.963, i.e., a decrease in
quality of life of 3.7%. Thirty-seven percent accepted death
risk according to the SG method; its mean utility was
0.9996. TTO outcomes correlated with current near and
distance visual acuity. Low acuity of the amblyopic eye,
chosen as most troubling eye disorder, ranked slightly less
severe than tooth decay.
Conclusion Amblyopia and/or strabismus patients had a
slightly decreased utility. The decrease is small but still
important in the cost-effectiveness of vision screening
because these conditions occur very frequently.
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Introduction
Amblyopia has a prevalence of approx. 3.4% [1], i.e.,
occurring very frequently. In a recent birth-cohort study it
was found that one quarter (0.8%) is insufficiently screened
and/or treated [1]. Cost-effectiveness analysis of vision
screening [2, 3] requires, among others, that the impact of
persistent amblyopia is transformed into an objectively
measurable form, a utility value. It was, to this end,
necessary to estimate the decrease in quality of life in
unilateral amblyopia and/or strabismus patients, as quanti-
fied by the applied utility analysis, wherein the burden of
disease, as perceived by patients, should be measured [4].
A recent birth-cohort study [5] could not detect a gross
decrease in quality of life due to insufficiently treated
amblyopia and/or strabismus at the level of education,
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employment and socioeconomic achievement. However, a
disease-specific quality-of-life instrument might well detect
such decrease at the level of visual day-to-day activities. We
had, to this end, developed the Amblyopia & Strabismus
Questionnaire (A&SQ). Clinical [6], content [7], and construct
[8] validity of this novel questionnaire has been confirmed.
A utility is the value (ranging from 1.0 perfect vision to 0.0
death) a patient assigns to his present health state, including
the disability caused by the current disease. A utility analysis
of amblyopia and/or strabismus was now performed in a
historic cohort of amblyopia and/or strabismus patients to
quantify their decrease in quality of life. In utility analysis, it is
imperative to measure decrease of quality of life in a
representative sample of the population. This necessity was,
for instance, demonstrated by our previous finding that quality
of life perception in amblyopic persons who came to an
outpatient clinic was much lower than in persons with similar
disability in the general population [7].
The subjects from our historic cohort were an almost
non-select sample of amblyopia and strabismus patients,
because all children who were suspected of amblyopia had
been referred between 1968 and 1974 to a single orthoptist
and a single ophthalmologist who served the entire Water-
land region.
In this study, utility was measured by the time trade-off
(TTO) and the standard gamble (SG) methods that are
commonly applied to derive direct patient preferences about
health states [9]. Most troubling eye disorder (low visual
acuity, lack of stereopsis, strabismus, glasses) was chosen
and ranked among nine adult chronic diseases according to
severity.
Methods and materials
Subjects were patients from the historic cohort. The historic
cohort was taken from all patients who had consulted the
orthoptist from the orthoptic outpatient clinic of the Water-
land Hospital in Purmerend, the Netherlands between 1968
and 1974 (N=1,250). From these subjects, born between
1962 and 1972, 471 had been occluded, and 201 could be
traced by telephone 30–35 years later. One hundred and
seventy four of these had filled out the A&SQ [7, 8]. One
hundred and thirty seven of them had been orthoptically re-
examined by orthoptists [6, 10]. The historic cohort formed
an almost non-select sample of all patients occluded at that
time, because all children with insufficient visual acuity or
strabismus from the entire region around Purmerend had
been referred to a single practicing ophthalmologist and
orthoptist at the time. The orthoptist had kept the original
charts of the 1,250 patients. Local birth rates of the villages
from the years in which most of the occluded were born
(1965, 1966, 1967) in this region had been derived as
previously described [6]. These indicated that the historic
cohort was representative for the children with amblyopia
within the entire population in the region at that time. Of
the children born in this region in 1965, 1966 and 1967,
4.8 % had received occlusion therapy [10].
Occlusion treatment and glasses had improved visual
acuity of the amblyopic eye to more than 0.5 (0.3 logMAR)
in one-third of patients. After occlusion therapy, visual acuity
had remained the same from the end of occlusion therapy until
adulthood in most patients, but children with combined-
mechanism amblyopia or increasing anisohypermetropia had
suffered a decrease of visual acuity of the amblyopic eye [10].
Subjects, after having given oral consent, were inter-
viewed by one researcher (ESvdG) face-to-face, at the
Waterland Hospital in Purmerend, and by phone. First, they
were asked how long they expected to live.
Bisectional top-down titration search procedure was used
to arrive at TTO and SG forced choices (See Appendix).
They were set against a hypothetical medicine that could
perfectly heal the eye condition (TTO) and a hypothetical
operation that could perfectly heal the eye condition (SG).
Most troubling eye condition (low visual acuity of
amblyopic eye, lack of depth perception, strabismus,
wearing glasses or other eye complaint) was chosen.
In order to perceive their reference values, subjects were
also presented with nine indicator conditions and the own
eye trouble to rank on a scale from 1 (least severe) to 10
(worst) [11] The indicator conditions were: chronic bron-
chitis, chronic ear infection, complete loss of smell,
complete loss of taste, eczema, migraine, partial deafness,
partial memory loss, tooth decay [12].
In an exploratory fashion, the measured utility values were
compared by correlation-analysis with the previously derived
results [7] in the five domains of the A&SQ: fear of losing
the better eye, distance estimation, visual disorientation,
diplopia, and social contact and cosmetic problems. This
was done to discern which of the functional restrictions
determined the impact of the current health state.
The measured utility values were also, in an exploratory
fashion, compared by correlation-analysis with the previ-
ously examined clinical parameters [6] of the amblyopia
and/or strabismus patients: distance visual acuity, near
visual acuity, binocular vision, angle of strabismus, latent
nystagmus, and refraction [13].
Results
Subjects
One hundred and thirty five subjects from the historic
cohort who, in a previous study [7] had filled out the
A&SQ (N=174) were interviewed, 106 in person, 29 by
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phone. Thirty eight subjects could not be included in the
study: 17 could not be reached, four were unable to be
interviewed (illness, other impairments), 11 refused to
participate, two did not meet the appointment. Male: N=72
(53%), female: N=63 (47%). Mean age of subjects was
40.86. Mean of expected life years of all subjects was
40.71 years.
Subjects chose as most troubling eye condition: low visual
acuity of the amblyopic eye (52), lack of depth perception
(31), strabismus (13), wearing glasses (14), none (eight).
Other troubling eye conditions were: dry or itching eyes
(three), fear of losing the better eye (four), diplopia (two),
impaired accommodation (one), tired eyes (two), having to
turn the head entirely to one side (two), deterioration of the
eyes (one), no depth perception in sunlight (one).
Utility values
The top-down search procedure (forced-choices) for the
TTO method resulted in 95 subjects (70%) who were
willing to trade some of their remaining life years in return
for perfect vision. From the 38 subjects with a visual acuity
of the amblyopic eye that had improved to >0.50 (0.3
logMAR) by occlusion therapy and retained this acuity for
30–35 years, 17 were not willing to trade any lifetime.
Mean of traded lifetime of all subjects, including those who
were unwilling to trade lifetime, was 11 months. Differen-
tiated to their most troubling eye condition, the mean traded
lifetime was 14.6 months for low visual acuity, 8.3 months
for lack of depth perception, and 7.2 months for strabismus.
Based on the calculation:
1 traded lifetime=expected life yearsð Þ
mean TTO utility value was: 0.977±0.0379. The TTO
mean logarithmic utility value was 0.963.
The top-down search procedure (forced-choices) for the
SG method resulted in 49 subjects (37%) who accepted
death risk, 86 subjects (63%) did not accept any death risk.
Mean of accepted death risk of all subjects, including those
who did not accept any death risk, was 1 in 20,000.
Differentiated to their most troubling eye condition, the
accepted death risk for low visual acuity was 1 in 10,000;
for lack of depth perception, 1 in 20,000; and for
strabismus, none.
Based on the calculation:
1 death risk taken
mean SG utility value was 0.9994±0.00307.
Ranking chronic disorders
Ranking of the nine chronic disorders with own eye
impairment according to subject’s perceived severity
showed that own eye impairment — mostly low visual
acuity of the amblyopic eye— was experienced as the least
severe disorder, less severe than eczema and tooth decay
(Fig. 1).
Correlations utility values
It was determined, in an exploratory fashion, whether
the measured utility values were associated with the
previously derived results in the five quality of life
domains of the A&SQ [7]. Pearson test of the TTO and
SG utilities was done according to a matrix format with
the data on the five A&SQ domains. It showed that only
the domain fear of losing the better eye correlated
significantly with the utility value assessed by the TTO.
None of the A&SQ domains correlated with SG utility
values (Table 1).
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Fig. 1 Ranking severity of
the ten disorders. Scores are
ranked scores from subjects.
Ranking scale was from 1,
least severe disorder, to 10
as the most severe disorder.
"Eye condition" comprises low
visual acuity of the amblyopic
eye, lack of depth perception,
strabismus, wearing glasses or
other eye complaints
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It was also determined, in an exploratory fashion,
whether the utility values correlated with the previously
derived clinical parameters: visual acuity, binocular vision,
angle of strabismus, refraction and latent nystagmus [6].
Pearson test of the TTO and SG utilities was done according to
a matrix format with previously examined clinical parameters.
It showed that the distance visual acuity and the near visual
acuity of the amblyopic eye correlated significantly with the
utility values assessed by the TTO (Table 2). The correlations
were, however, weak. We had expected better correlations
between measured TTO values and clinical parameters,
because in the clinical validation study, the visual acuity of
the amblyopic eye correlated significantly with quality of life
as measured by four A&SQ domains [6].
None of the clinical parameters correlated significantly
with SG utilities (Table 2)
Discussion
Utility in amblyopia and/or strabismus patients is lower than
in healthy persons: 70% of all 135 subjects were willing to
trade lifetime for perfect vision. The mean logarithmic TTO
utility value of unilateral amblyopia and/or strabismus in adult
patients was 0.963. This mean value included the subjects
(30%) unwilling to trade any lifetime. It is equal to an
estimated decrease in quality of life due to amblyopia and/or
strabismus of 3.7%. This small decrease is important in cost-
effectiveness of prevention of amblyopia, as amblyopia and
strabismus are very frequent conditions.
Thirty-seven percent of all 135 subjects accepted death risk
to achieve perfect vision. The mean SG utility value of
unilateral amblyopia and/or strabismus in adult patients was
0.9994, including the subjects unwilling to accept death risk.
Clearly, the decrease of utility value of amblyopia is not
the same as that of acquired unilateral visual loss that has
been reported to be 0.83 [4, 14].
The recruitment of the patients from a historic cohort
of 471 occluded amblyopia and/or strabismus patients
contributed to the unbiased character of the study
outcomes. All children with insufficient visual acuity
or strabismus from the Waterland area had been referred
to the single ophthalmologist and orthoptist, and there had
been little migration in this area between 1968 and 1974.
Hence, almost all of these children within this region had
been treated within this hospital and were eligible for this
study [6].
We were interested to know whether the subjects who
were willing to trade much lifetime or did accept death risk
had low quality of life as found by the A&SQ. The TTO
Table 2 Past and current orthoptic parameters correlated to the utility values (TTO and SG)
Utility values Examined orthoptic parameters
VA ambly. eye
(start occl.)
VA ambly. eye
(end occl.)
VA ambly. eye
(current)
Reading VA
ambly. eye
Anisometropia
r P** r P** r P** r P** r P**
TTO -.196 .038* -.237 .010* -.305 .001** -.211 .023* .211 .024*
SG -.103 .277 -.005 .956 .011 .908 .009 .921 .093 .326
r: Pearson correlation (two-tailed) of the utility values with the orthoptic parameters
Levels of significance (two-tailed): *P=0.01-0.05; **P <0.01
Abbreviations: ambly.: amblyopic; occl.: occlusion: VA: visual acuity
Table 1 Utility values (TTO and SG) correlated to the five A&SQ domains
Util. Val. Five domains of the A&SQ
Fear loss better eye Distance estim. Visual disorient. Diplopia Contact & cosmetic
r P* r P* r P* r P* r P*
TTO .207 .027* .161 .063 .162 .060 -.037 .671 -.086 .320
SG .061 .521 -.029 .735 -.034 .698 -.049 .574 -.097 .264
r: Pearson correlation (two-tailed) of the utility values with the A&SQ domains
Level of significance (two-tailed): *P=0.01–0.05
Abbreviations: estim.: estimation; disorient.: disorientation
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utility values correlated significantly only with the domain
fear of losing the better eye, out of the five A&SQ domains
(Table 1). Indeed, patients with insufficiently treated
amblyopia spend on average the last 15 months of their
lives with bilateral visual impairment when they lose the
function of the better eye, in comparison to 8 months in
healthy persons [15].
Similarly, visual acuity of the amblyopic eye was
found to relate to quality of life in four ways. Low
visual acuity of the amblyopic was perceived as the
most troubling eye disorder. Subjects with low visual
acuity were most willing to trade lifetime for perfect
vision. They were also most willing to accept death risk
in exchange for perfect vision. Finally, the utility, as
measured by TTO, correlated with the distance and near
visual acuity of the amblyopic eye.
This implies that good vision screening and good
occlusion therapy are of major importance for quality of
life in amblyopia and/or strabismus patients.
Conclusion
Amblyopia and/or strabismus patients — in an almost non-
select sample — had a slightly decreased utility. The
decrease is small but still important in cost-effectiveness of
treatment and prevention of amblyopia, as amblyopia and
strabismus occur very frequently.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Appendix
TTO bisectional top-down titration search alternatives for
trading lifetime were:
No time or 1 day>1 week>1 month>3 months>6 months
5 years>2 years>1 year>6 months,
SG bisectional top-down titration search alternatives for
accepted risk of dying were:
No or one person dying in 20,000>10,000>1,000
One person dying in 50>100>200>1,000
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